ExploraMed

Revelle Aesthetics is a company focused on developing innovative medical devices in the aesthetics sector, specifically targeting women's aesthetic concerns. Originating from ExploraMed, a prominent medtech incubator, Revelle Aesthetics aims to address significant issues such as cellulite through advanced solutions. The company is committed to delivering reliable outcomes for practitioners and meaningful results for women, leveraging the expertise of a passionate team in the medical device and aesthetics industries.

Willow, founded in 2014 and based in Mountain View, California, is a company that specializes in the development and manufacturing of wearable breast pumps and related breastfeeding products. The company offers a range of items including in-bra breast pumps, milk bags, replacement parts, pumping bras, and accessories like flanges and chargers. Willow's breast pumps are designed to be mobile and hands-free, allowing mothers to pump discreetly and conveniently. The devices are cordless, spill-proof, and equipped with a mobile application that tracks milk output, facilitating a hassle-free pumping experience for mothers on the go.

Nuelle is a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women. It marries its experience in healthcare solutions, consumer products, and technology with a deep understanding of women’s unfulfilled needs. From inception, Nuelle has taken a holistic view of these needs and desires. They worked closely with thought leaders and experts in women’s sexual medicine and wellness including physicians, sex therapists, physical therapists, and psychologists. Together we developed insights that allow Nuelle to translate its scientific approach to understanding.

Vibrynt operates in the medical device sector and offers a system designed to assist with weight loss by limiting food consumption.

Moximed, Inc. is a medical technology company based in Hayward, California, focused on developing innovative solutions for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain for individuals suffering from medial compartment knee osteoarthritis. This system operates similarly to a shock absorber, providing dynamic load reduction to minimize joint pain and enhance mobility. Moximed also features the MISHA Knee System, which offers an outpatient treatment option for patients who have not found relief through other therapies and are not suitable candidates for knee replacement surgery. By addressing the specific needs of osteoarthritis patients, Moximed aims to improve their quality of life while potentially delaying the need for more invasive surgical interventions. Founded in 2006, the company serves patients and medical professionals worldwide.

NeoTract, Inc. is a medical device company specializing in minimally invasive solutions for urological disorders. Founded in 2004 and headquartered in Pleasanton, California, it develops the UroLift system, which is specifically designed for men suffering from enlarged prostate. This system addresses symptoms effectively while preserving normal sexual function. NeoTract serves a diverse customer base across the United States, Europe, Australia, Canada, Mexico, and South Korea. As a subsidiary of Teleflex Urology Limited, the company is committed to providing innovative clinical devices that improve patient outcomes in urology and gynecology.

Acclarent, Inc. is a medical device company focused on developing innovative technologies for ear, nose, and throat (ENT) patients. The company's primary emphasis is on balloon sinuplasty devices, which are minimally invasive tools designed to assist physicians in treating chronic sinusitis. These devices enable doctors to navigate the sinus anatomy and open blocked sinus ostia and passageways, facilitating sinus drainage. Acclarent's Balloon Sinuplasty technology and the Relieva product portfolio provide alternatives to conventional endoscopic surgical methods. The company received FDA clearances for its devices in 2005 and launched them commercially in the United States that same year, marking a significant advancement in sinus surgery.